Conneqt HealthASX:CQT 3-Year RORE % is -12.50 as of Dec. 2025. The stock has 8 warning signs investors should review. Among 781 Medical Devices & Instruments companies, Conneqt Health ranks worse than 59.03% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Conneqt Health's 3-Year RORE % for the quarter that ended in Dec. 2025 was -12.50%.
The industry rank for Conneqt Health's 3-Year RORE % or its related term are showing as below:
ASX:CQT's 3-Year RORE % is ranked worse than 59.03% of 781
companies
in the Medical Devices & Instruments industry
Industry Median: -4.03
vs ASX:CQT: -12.50
Conneqt Health (ASX:CQT) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Conneqt Health 3-Year RORE % Related Terms
Conneqt Health 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Conneqt Health's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CQT vs ABT, SYK, MDT: 3-Year RORE % Comparison
For the Medical Devices subindustry, Conneqt Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conneqt Health 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conneqt Health's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Conneqt Health's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Conneqt Health (ASX:CQT) has a 3-Year RORE % of -12.50 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Conneqt Health and its competitors. According to the industry distribution chart, Conneqt Health ranks #461 out of 781 companies in the Medical Devices & Instruments industry, placing it in the top 59%.
Is Conneqt Health's 3-Year RORE % too high?
Conneqt Health's current 3-Year RORE % is -12.50. Based on the distribution chart, Conneqt Health ranks #461 out of 781 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Conneqt Health's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conneqt Health ranks #461 out of 781 companies for 3-Year RORE %. This places Conneqt Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Conneqt Health and its competitors. Conneqt Health's current 3-Year RORE % is -12.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conneqt Health stock overvalued right now?
Based on GuruFocus' analysis, Conneqt Health (ASX:CQT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 30% below its estimated fair value. The current 3-Year RORE % is -12.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Conneqt Health (ASX:CQT), the current 3-Year RORE % is -12.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Conneqt Health Ltd is a health technology company, developing solutions for health disorders. The company designs medical devices for use in cardiovascular health management. The company is mainly engaged in manufacturing biomarkers that helps to detect associated risks, optimize heart health, and empower good cardiovascular decisions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CQT has been successfully added to your 